Guidelines for Shared Decision-Making in Chronic Care

Abstract

Shared decision-making (SDM) has emerged as a cornerstone of patient-centered chronic care, aiming to integrate clinical evidence with patient preferences for optimal outcomes. This review evaluates current guidelines, epidemiological trends, underlying pathophysiology, risk stratification, clinical features, diagnostic approaches, treatment paradigms, recent advances, and practical guideline recommendations. Emphasizing the mechanisms and benefits of SDM, the article provides clinicians with actionable insights for implementing SDM in chronic disease management, highlights barriers and facilitators, and discusses future directions for improving patient engagement and care quality.

Introduction

Chronic diseases such as diabetes, cardiovascular diseases, chronic respiratory conditions, and cancer represent the leading causes of morbidity and mortality worldwide. The complexity and lifelong nature of these conditions necessitate sustained engagement between patients and healthcare teams. Shared decision-making (SDM), which involves collaborative deliberation between clinicians and patients, is now integral to evidence-based practice. SDM fosters informed consent, respects autonomy, and tailors interventions to individual values, resulting in improved adherence and satisfaction. This review synthesizes the current evidence and guideline recommendations to support SDM in chronic care, addressing epidemiological, mechanistic, diagnostic, and therapeutic aspects, with a focus on practical implementation for healthcare professionals.

Epidemiology / Disease Burden

Chronic diseases account for approximately 71% of all deaths globally, with non-communicable diseases (NCDs) leading the burden. According to the World Health Organization, over 1.7 billion people live with at least one chronic disease. The aging global population, lifestyle changes, and improved survival rates have increased the prevalence of multimorbidity, making chronic care a central focus of modern medicine. The psychological, social, and economic impacts of chronic diseases underscore the necessity for patient-centered care models, particularly those that empower patients through SDM.

Pathophysiology

Chronic diseases are characterized by prolonged progression, multifactorial etiology, and complex pathophysiology involving genetic, environmental, and behavioral factors. For instance, type 2 diabetes involves insulin resistance, beta-cell dysfunction, and chronic inflammation; heart failure is driven by neurohormonal activation and myocardial remodeling. The protracted course of these conditions often entails nuanced therapeutic choices, evolving risk profiles, and a need for ongoing risk-benefit reassessment—all of which make SDM particularly relevant. Understanding the underlying mechanisms helps clinicians convey disease trajectories and treatment rationales to patients, enhancing SDM discussions.

Risk Factors

Risk stratification is central to SDM in chronic care, as it informs preventive and therapeutic options. Modifiable risk factors such as tobacco use, physical inactivity, poor diet, obesity, dyslipidemia, hypertension, and psychosocial stress are commonly implicated across chronic conditions. Non-modifiable factors include age, sex, genetic predisposition, and family history. Effective SDM requires clinicians to contextualize these risks for patients, translating epidemiological data into personalized risk assessments that guide shared choices around screening, lifestyle changes, and pharmacotherapy.

Clinical Features

Chronic diseases present with heterogeneous clinical features, often including insidious onset, fluctuating symptoms, and periods of exacerbation and remission. For example, chronic obstructive pulmonary disease (COPD) may manifest as progressive dyspnea, cough, and fatigue, while heart failure is marked by fluid retention, exercise intolerance, and arrhythmias. Recognizing individual symptom patterns, comorbidities, and patient-reported outcomes enables tailored SDM discussions. Clinicians should elicit and validate patients\' experiences, functional limitations, and goals, integrating these insights into the decision-making process.

Diagnosis

Accurate diagnosis in chronic care often involves integrating clinical evaluation, laboratory testing, and imaging. The diagnostic journey can be lengthy and emotionally taxing, with potential for uncertainty and evolving findings. SDM plays a critical role in diagnostic decisions, such as selecting among invasive versus non-invasive investigations, periodic monitoring, and managing incidental findings. Evidence-based decision aids and risk calculators can support transparent communication of diagnostic probabilities, trade-offs, and next steps, ensuring patients are informed and empowered participants in their care trajectory.

Treatment & Management

Chronic care management encompasses pharmacologic therapies, lifestyle interventions, rehabilitative services, and psychosocial support. Therapeutic choices are rarely straightforward, given the need to balance efficacy, safety, tolerability, cost, and patient preferences. SDM is particularly vital when multiple guideline-concordant options exist, or when interventions offer marginal benefits with substantial harms or burdens. Tools such as option grids, patient leaflets, and structured counseling can facilitate SDM, enabling patients to weigh pros and cons in the context of their values, life circumstances, and goals of care.

Recent Advances / Emerging Therapies

Recent advances in chronic care include digital health solutions, remote monitoring, personalized medicine, and artificial intelligence-driven risk prediction. These innovations offer new opportunities and challenges for SDM. For instance, continuous glucose monitoring in diabetes, telemedicine for heart failure, and biologic therapies for rheumatologic diseases have expanded the therapeutic landscape. SDM helps patients and clinicians navigate the expanding array of choices, integrating real-time data and evidence to inform personalized care pathways. The development and validation of SDM tools, including decision aids and communication frameworks, represent a key area of ongoing research.

Guideline Recommendations

Leading organizations such as the American College of Physicians, National Institute for Health and Care Excellence (NICE), and World Health Organization endorse SDM as a best practice in chronic care. Key recommendations include: systematically eliciting patient values and preferences; presenting evidence-based options with clear risk-benefit profiles; addressing health literacy and numeracy; and documenting SDM processes in the medical record. Barriers such as time constraints, lack of training, and cultural factors should be addressed through institutional support, clinician education, and integration of SDM into clinical workflows. Practice guidelines increasingly incorporate SDM as a quality indicator, reinforcing its centrality in chronic disease management.

Conclusion

Shared decision-making is foundational to high-quality, patient-centered chronic care. By integrating clinical evidence with patient preferences and context, SDM improves engagement, adherence, and outcomes. Clinicians should systematically implement SDM, supported by evidence-based tools and guideline recommendations, to optimize care for individuals living with chronic diseases. Ongoing research and innovation will further refine SDM strategies, ensuring they remain responsive to evolving healthcare challenges and patient needs.